Brief: Genetron Health And CStone Pharmaceuticals Announce Launch Of Clinical Trial In China For Companion Diagnostic Test In Development For Avapritinib
25/09/2020 11:02
Sept 25 (Reuters) - CStone Pharmaceuticals 2616.HK :
* GENETRON HEALTH AND CSTONE PHARMACEUTICALS ANNOUNCE LAUNCH
OF
CLINICAL TRIAL IN CHINA FOR COMPANION DIAGNOSTIC TEST IN
DEVELOPMENT FOR AVAPRITINIB
Source text for Eikon: ID:nGNX9NKQb8
Further company coverage: 2616.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Genetron Holdings
See all newsBrief: Genetron Holdings Requested That Trading Of Its ADSs On Nasdaq Be Suspended As Of Close Of Trading On March 28, 2024
U.S. STOCKS ON THE MOVE-Cerevel Therapeutics, Scholar Rock, Helius
U.S. STOCKS ON THE MOVE-Scholar Rock, Target, LL Flooring
U.S. STOCKS ON THE MOVE-First Solar, Genetron, Viasat
Genetron surges on $126 mln deal to go private